A Family-centred Approach Enhancing Cardiovascular Health in Ugandan Adolescents and Their Families
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age10-19
SponsorMRC/UVRI and LSHTM Uganda Research Unit
About this trial
The FaCe-D Study, with funding from the Canadian Institute for Health Research (CIHR) through Global Alliance for Chronic Diseases (GACD) aims to adapt and implement an evidence-based family centred approach (FCA) to prevent cardiovascular diseases (CVD) among adolescents and their families. This 5-year implementation science study will be conducted in 16 villages in Jinja district and another 16 in Kampala beginning April 2024 to evaluate the effectiveness of FCA in reducing the risk of CVD in Uganda and to assess feasibility, adoption, while measuring the costs of implementation. The study will be implemented by a group of researchers from MRC/UVRI \& LSHTM, University of British Columbia (Canada), TASO (Uganda) and University of California San Francisco (UCSF) - USA with guidance from the Ministry of Health - Uganda.
Eligibility criteria
Qualifiers
Aged 10 -19 years
Household head/parent has provided consent/permission
Planning to continue staying in the study village for the next 12 months
Disqualifiers
In a boarding school or planning to join a boarding school
Pregnant or lactating
Known to have a chronic condition such as mental illness
The adolescent does not assent or consent
Trial design
Treatments tested in this trial
- The immediate (treatment) arm, will receive the FaCe-D intervention comprising of 'HOME VISITS, DIET, PHYSICAL ACTIVITY AND HEALTH MESSAGING
- Control Arm - standard of care
Treatment groups
1,280 Participants
are divided into 2 treatment groupsSponsors and collaborators
MRC/UVRI and LSHTM Uganda Research Unit
Lead sponsor
University of California
Collaborator
The AIDS Support Organization
Collaborator
University of British Columbia
Collaborator
Source ClinicalTrials.gov